Pharmacy Update: Lorazepam - Critical Shortage

12/12/2023
Author: Kamal Sandhu, PharmD, BCPS Manager, Clinical Pharmacy Services

 

We are unfortunately once again facing a critical shortage of IV/IM lorazepam (2mL vials) and down to a limited supply (~2 weeks).  We will be implementing an EPIC alert but wanted to also notify you directly due to the far reaching nature of this shortage.

For clinical scenarios that require IV/IM lorazepam critically (e.g. status epilepticus): please proceed with order.   Otherwise, some options for managing this shortage include:

  • Utilize PO lorazepam whenever possible (dosing conversion is 1:1)
  • For ED/CCU/procedural areas – consider utilizing midazolam if able. 
  • For med/surg areas, consider IV diazepam (avoid IM due to erratic absorption) if able.

NOTE: There are no direct dosage conversions between the benzodiazepines because each has a distinct pharmacokinetic profile that dictates the agent's therapeutic use and dosing.  Below are conservative recommendations and information regarding the onset and duration.

Agent

Onset of Action (min) – Intravenous 

Duration of Action (hours) – Intravenous 

Onset of Action (min) – Intramuscular 

Duration of Action (hours)  -  Intramuscular 

Half Life (hours) 

Conservative estimate on equivalent dose1

Lorazepam

5 to 20

6 to 8

15 to 30

6 to 8

8 to 15

1mg

Diazepam

1 to 5

0.3 to 0.5

Erratic/slow

Erratic/slow

20 to 120

5mg

Midazolam

1 to 5

< 2

5 to 15

< 2

3 to 11

2mg

  1. Clinicalc.com/benzodiazepine
  2. ASHP Drug Shortages - Lorazepam (injectable)

AttentionX

Please note you have left MyChart and have been re-directed to Valley Medical Center's Find-a-Provider tool.

While on this site, if you click on a MyChart sign-in link, you will be required to log in again.